Close Menu

In Science Translational Medicine this week, investigators at Stanford University School of Medicine show that miR-21 "blocks abdominal aortic aneurysm development and nicotine-augmented expansion." Because of this, the authors suggest modulation of its expression "shows potential as a new therapeutic option to limit AAA [abdominal aortic aneurysm] expansion and vascular disease progression."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.